Showing 21 - 25 results of 25 for search '"National Health Research Institutes"', query time: 0.09s Refine Results
  1. 21
    Disrupted HIV care during COVID-19 pandemic associated with increased disabilities among people living with HIV in Belize

    Disrupted HIV care during COVID-19 pandemic associated with increased disabilities among people living with HIV in Belize by Tracy M. Quetzal, Wei-Cheng Lo, Ya-Wen Chiu, Hung-Yi Chiou

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 22
    Trends in palliative care utilization among older adult decedents with and without cancer in Taiwan: a population-based comparative studyResearch in context

    Trends in palliative care utilization among older adult decedents with and without cancer in Taiwan: a population-based comparative studyResearch in context by Yu-Tai Lo, Tzu-Jung Chuang, Yu-Tung Huang, Yi-Lin Wu, Yi-Ching Yang, Chung-Yi Li

    Published 2025-02-01
    “…Funding: This study was supported in part by grants from the National Cheng Kung University Hospital (NCKUH-11305001, NCKUH-V101-10) and the National Health Research Institutes (NHRI-13A1-CG-CO-04-2225-1). …”
    Get full text
    Article
    Save to List
    Saved in:
  3. 23
    Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis

    Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis by Ryunosuke Nakagawa, Kouji Izumi, Kaoru Hiratsuka, Takahiro Inaba, Yoshiki Koketsu, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Hiroki Nakata, Wen-Jye Lin, Atsushi Mizokami

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 24
    Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

    Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE) by Chee Khoon Lee, PhD, Bin-Chi Liao, MD, Shalini Subramaniam, MMed (Clin Epi), Chao-Hua Chiu, MD, Antony J. Mersiades, MMed (Clin Epi), Chao-Chi Ho, MD, PhD, Chris Brown, MBiostats, Chun-Liang Lai, MD, PhD, Brett G.M. Hughes, M.B.B.S. (Hons), Tsung-Ying Yang, MD, PhD, Ken O’Byrne, MD, Yung-Hung Luo, MD, PhD, Sonia Yip, PhD, Ching-Liang Ho, MD, Victoria Bray, PhD, Wu-Chou Su, MD, PhD, Melissa Moore, PhD, Wei-Lien Feng, MS, Ya-Ying Bai, MS, Kate Ford, MHSc, Michelle M. Cummins, PhD, Martin R. Stockler, MSc (Clin Epi), Benjamin J. Solomon, PhD, Thomas John, PhD, James Chih-Hsin Yang, MD, PhD

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 25
    Regulation of interferon alpha production by the MAGUK-family protein CASK under H5N1 infection

    Regulation of interferon alpha production by the MAGUK-family protein CASK under H5N1 infection by Jing-Ying Huang, Jing-Ying Huang, Pei-Shan Sung, Shie-Liang Hsieh, Shie-Liang Hsieh, Shie-Liang Hsieh, Shie-Liang Hsieh

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: